ArticleThe New England journal of medicine2012
Confronting multidrug-resistant tuberculosis.
Article in The New England journal of medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis.BMC microbiology · 2019Pooled it
- Pooled it
- Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.The Cochrane database of systematic reviews · 2014Pooled it
- Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.The Cochrane database of systematic reviews · 2013Pooled it
- Impact of Drug-Resistant Tuberculosis Prevention and Control Strategies in Southeast China: Evidence from a Longitudinal Study on Disease Epidemic Trends and Predictions Across 15 Years.Infection and drug resistance · 2026Article
- Molecular characterisation of rifampicin-resistantAfrican journal of laboratory medicine · 2017Article
- Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis.Scientific reports · 2016Article
- Discovery of novel drug targets and their functions using phenotypic screening of natural products.Journal of industrial microbiology & biotechnology · 2016Review
- Improving health services for African migrants in China: A health diplomacy perspective.Global public health · 2014Article
- Getting health services to three million people with TB.Journal of the International AIDS Society · 2014Article
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis.Nature medicine · 2013Article
- Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.Medical microbiology and immunology · 2013Review
- Increase in multidrug-resistant tuberculosis (MDR-TB) in Alberta among foreign-born persons: implications for tuberculosis management.Canadian journal of public health = Revue canadienne de sante publique · 2013Article
- Multidrug-resistant tuberculosis.The New England journal of medicine · 2012Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Comment on
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
22670908What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.